Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$26,606,957
+$6,418,926 QoQ
Shares Held
22,183
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.66%
of 13F equity value
Holder Rank
#768
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODMONT INVESTMENT COUNSEL LLC holds $91,634,066 across 9 Drug Manufacturers - General names. LLY ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
22,183 | $26,606,957 | |
| 2 | JNJ |
Johnson & Johnson
|
92,061 | $23,380,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
173,179 | $22,253,501 | |
| 4 | PFE |
Pfizer Inc
|
284,542 | $6,851,771 | |
| 5 | ABBV |
AbbVie Inc.
|
22,718 | $5,716,757 | |
| 6 | NVS |
Novartis AG
|
27,118 | $4,249,932 | |
| 7 | NVO |
Novo Nordisk A S
|
27,438 | $1,315,377 | |
| 8 | AMGN |
Amgen Inc
|
1,805 | $653,626 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,606,957 | 22,183 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $20,188,031 | 21,949 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $22,374,839 | 20,820 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $15,807,071 | 20,717 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $15,520,442 | 19,910 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $10,717,834 | 12,977 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $8,250,364 | 10,687 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,279,976 | 4,831 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,411,011 | 4,872 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,761,436 | 4,835 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,775,282 | 4,761 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,429,976 | 4,524 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,164,811 | 4,616 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,727,746 | 5,031 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,727,130 | 4,721 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,526,535 | 4,721 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,546,901 | 4,771 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,308,997 | 4,571 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,435,239 | 5,196 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,200,535 | 5,196 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,199,471 | 5,226 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $976,321 | 5,226 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $879,825 | 5,211 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $707,683 | 4,781 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $793,153 | 4,831 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $680,560 | 4,906 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||